Research
The U.S. Department of Justice (DOJ) recently joined two additional agencies in hosting a Regional Smuggling Forum and Roundtable event in Mexico City.
The U.S. Department of Homeland Security (DHS) and the State Department’s Bureau of International Narcotics and Law Enforcement Affairs (INL)... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) this week awarded four grants totaling approximately $4.3 million of investment over the first year alone to launch new Tuberculosis Research Advancement Centers (TRACs) across the country.
These grants will last five years,... Read More »
A supplemental Biologics License Application (sBLA) for Roche’s Actemra/RoActemra intravenous treatment for COVID-19 cases among hospitalized patients was accepted by the United States Food and Drug Administration (FDA) this week and will benefit from priority review.
If approved, the drug... Read More »
Updates are on the way for the existing perimeter intrusion detection and assessment system (PIDAS) and other security features at the Y-12 National Security Complex in Tennessee, care of a $100 million endeavor from the National Nuclear Security Administration (NNSA).
Groundbreaking for the... Read More »
Within 10 years, the World Health Organization (WHO) sees a path to increase the use of and access to genomic surveillance for monitoring and analyzing pathogens through a strategy targeting inequities and leveraging existing capacities.
Genomic surveillance is a process whereby pathogens are... Read More »
The life of N95 masks – a component in fighting the spread of COVID-19 – may be extendable for far longer than initially thought with the use of ultraviolet light, according to recent research from the National Institute of Standards and Technology (NIST).
In a study published in the Journal... Read More »
Together, the Cybersecurity and Infrastructure Security Agency (CISA), Federal Bureau of Investigation (FBI), and United States Department of Energy (DOE) recently warned that action is needed to counter the ongoing threat of state-sponsored Russian cyber operations to the U.S. energy sector and... Read More »
Interim data emerged this week from a Phase 2/3 trial of Moderna, Inc.’s mRNA-1273 COVID-19 vaccine on children between 6 months and 6 years old, demonstrating efficacy similar to usage on adults and with a generally well-tolerated profile.
The KidCOVE trial provided participants with two 25... Read More »
The Defense Advanced Research Projects Agency (DARPA) recently launched a space-based manufacturing exploration initiative targeting future space structure production on-orbit without volume constraints.
The agency's Novel Orbital Moon Manufacturing, Materials, and Mass Efficient Design (NOM4D)... Read More »
In a study conducted on non-human primates, Soligenix, Inc.’s CiVax COVID-19 booster vaccine candidate produced increased neutralizing antibody responses to SARS-CoV-2 and its Delta Omicron variants.
The results, released last week, showed the heat-stable vaccine candidate generated as much... Read More »
The more detail provided on a disease, the better for doctors to pursue proper treatment, and in that regard, Roche and its subsidiary TIB Molbiol announced this week that they have tests capable of identifying between the Delta variant and various Omicron subvariants of SARS-CoV-2.
These tests... Read More »
With an eye on potential vaccine development, the Coalition for Epidemic Preparedness Innovations (CEPI) announced this week that it will expand its partnership with Bangladesh’s icddr,b for a study into survivors of the deadly Nipah virus.
This support will take the form of nearly $1 million... Read More »
The Director of National Intelligence (DNI) research and development arm, the Intelligence Advanced Research Projects Activity (IARPA), has initiated the Biometric Recognition & Identification at Altitude and Range (BRIAR) program.
“National security technologies must accurately and reliably... Read More »
The U.S. Department of Homeland Security (DHS) recently released a report that seeks to assess efforts to maximize preventing, detecting, and responding to potential domestic violent extremism threats.
“Every day, the more than 250,000 dedicated public servants at DHS work to ensure the safety... Read More »
Dosing officially began last week in a Phase 2 trial of Moderna’s COVID-19 Omicron variant-specific, bivalent booster vaccine candidate.
Known currently as mRNA-1273.214, the candidate combines another Omicron booster candidate with Moderna’s official COVID-19 vaccine, mRNA-1273.
"We are... Read More »
In a new report released this week, the nonprofit Trust for America’s Health (TFAH) called out gaps in states’ emergency response capabilities and advocated for urgent investment in a new public health system.
The report, Ready or Not 2022: Protecting the Public’s Health from Diseases,... Read More »
The Auburn University College of Veterinary Medicine (AUCVM) has been awarded a five-year, $24 million Department of Homeland Security (DHS) Science and Technology Directorate (S&T) canine development contract.
“Canines are an important tool in support of the S&T mission to prevent and respond... Read More »
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) began a clinical trial this week investigating rare but potentially serious systemic allergic reactions to COVID-19 mRNA vaccines.
“People who experienced an allergic reaction after receiving a COVID-19 mRNA... Read More »
Efforts are underway to study the possibilities of oral smallpox treatment TPOXX as a post-exposure prophylactic (PEP), with the announcement of clinical trials by SIGA Technologies, Inc. last week.
These trials will support a U.S. Food and Drug Administration (FDA) label expansion for the drug,... Read More »
The primary goal of the international COVID-19 Technology Access Pool (C-TAP) to facilitate access to COVID-19 health products received a major boost last week with an offer from the U.S. National Institutes of Health (NIH) for several related technologies.
These offers would allow potential... Read More »
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) recently released a Request for Information (RFI) to obtain first responder new and emerging technologies.
First responders would experiment with and test the technological offerings during the multi-day... Read More »
Global aerospace company Boeing is detailing the construction of the latest Wideband Global SATCOM (WGS) satellite system version, highlighting advanced techniques effectively integrating commercial technology.
"We're moving at record-breaking speed to deliver the unmatched resilience,... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will continue long-standing partnerships with GlaxoSmithKline (GSK), Sanofi, and Seqirus to build up medical countermeasures to influenza pandemics and other public health emergencies.
For years, these partnerships and other... Read More »
With test data showing their COVID-19 vaccine’s capabilities to fight COVI-19 in regular or booster form, Sanofi and GSK announced this week that they intend to submit data as the foundation of regulatory authorization requests.
The Sanofi-GSK offering is a refrigerator temperature-stable,... Read More »
Nuclear Threat Initiative (NTI) and Munich Security Conference (MSC) personnel are espousing the benefits of a recently convened tabletop exercise to reduce high-consequence biological threats.
The effort involved uniting senior leaders from across government, industry, and civil society to... Read More »
Following an endorsement from the independent Data and Safety Monitoring Board this week, Moderna, Inc. officially began the third phase of trials for its mRNA Respiratory Syncytial Virus (RSC) vaccine candidate this week.
The safety greenlight was based on preliminary Phase 2 safety and... Read More »
A virtual event organized by the Coalition for Epidemic Preparedness Innovations (CEPI), the Johns Hopkins Center for Health Security, and the German Federal Ministry of Education and Research last week pulled in government officials and technical experts to address the best means of accelerating... Read More »
The ReVector program – an anti-mosquito Defense Advanced Research Projects Agency (DARPA) creation undertaken at Stanford University – entered its next research phase this month, advancing to animal testing.
“Phase 1 of the program focused on identifying microbial or metabolic targets... Read More »
A group of Republican legislators recently forwarded correspondence to President Joe Biden, seeking clarity on re-imposing limits on ground-based missiles in Europe and the Indo-Pacific.
U.S. Reps. Mike Gallagher (R-WI), Mike Rogers (R-AL), Michael McCaul (R-TX), Michael Turner (R-OH), Elise... Read More »
The National Institutes of Health (NIH) last week announced the allocation of $4.5 million across three grant awards to create collaborative research centers in the United States, focusing specifically on investigating treatments and vaccines specifically related to Valley Fever.
These centers... Read More »
Years into a global pandemic, the Access to COVID-19 Tools (ACT) Accelerator and affiliated world leaders have called for fair, shared-based financing of approximately $23 billion in 2022 to overcome inequalities in medical access, scale-up countermeasure efforts, and end the COVID-19... Read More »
The U.S. Department of Homeland Security (DHS) Small Business Innovation Research (SBIR) Program is seeking information regarding building collapse search and rescue technologies.
The DHS Science and Technology Directorate (S&T) administered SBIR Program has issued an Other Agency Technology... Read More »
Phase 2 testing of a Lyme disease vaccine candidate, VLA15, produced strong immune responses, according to the newest data from Valneva SE and Pfizer inc, prompting preparations for a Phase 3 study in the third quarter of 2022.
The VLA15-221 trial produced stronger responses in adult... Read More »
The Office of Justice Programs’ (OJP) National Institute of Justice (NIJ) has released study findings regarding traits of persons who engaged in mass shootings between 1966 and 2019.
“This study — one of the most extensive assessments of mass violence to date—reveals a deeply unsettling... Read More »
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) released a new Pandemic Preparedness Plan this week, directing its research efforts toward identifying pathogens with potential for significant spread among humans and those already known to be major threats.
Informed by a... Read More »
